DNA
Price
$11.80
Change
-$1.20 (-9.23%)
Updated
Oct 12, 04:59 PM (EDT)
Capitalization
704.38M
35 days until earnings call
Intraday BUY SELL Signals
LRND
Price
$48.86
Change
+$0.05 (+0.10%)
Updated
Oct 12, 10:47 AM (EDT)
Net Assets
463.36M
Intraday BUY SELL Signals
Interact to see
Advertisement

DNA vs LRND

DNA vs LRND Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DNA vs. LRND commentary
Oct 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNA is a Hold and LRND is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
TECHNICAL ANALYSIS
Technical Analysis
DNALRND
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
66%
Momentum
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
COMPARISON
Comparison
Oct 12, 2026
Stock price -- (DNA: $13.00)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNA’s FA Score shows that 1 FA rating(s) are green while .

  • DNA’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNA’s TA Score shows that 7 TA indicator(s) are bullish.

  • DNA’s TA Score: 7 bullish, 3 bearish.

Price Growth

DNA (@Biotechnology) experienced а +5.26% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.38%. For the same industry, the average monthly price growth was -10.93%, and the average quarterly price growth was -10.95%.

Reported Earning Dates

DNA is expected to report earnings on Nov 16, 2026.

Industries' Descriptions

@Biotechnology (-4.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DNA
Daily Signal:
Gain/Loss:
LRND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HKPD0.110.01
+11.11%
Cellyan Biotechnology Co Ltd
NTRB6.650.60
+9.92%
Nutriband
CRL301.793.79
+1.27%
Charles River Laboratories International
GRND15.030.09
+0.60%
Grindr
MPLT8.83-0.32
-3.50%
MapLight Therapeutics Inc.

DNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNA has been loosely correlated with VCYT. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if DNA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNA
1D Price
Change %
DNA100%
+14.64%
VCYT - DNA
58%
Loosely correlated
+3.74%
RXRX - DNA
56%
Loosely correlated
+10.38%
TWST - DNA
55%
Loosely correlated
+5.08%
ABSI - DNA
50%
Loosely correlated
+13.65%
CRSP - DNA
48%
Loosely correlated
+5.85%
More

LRND and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRND has been loosely correlated with DNA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LRND jumps, then DNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRND
1D Price
Change %
LRND100%
+0.59%
DNA - LRND
42%
Loosely correlated
+14.64%
DBX - LRND
41%
Loosely correlated
+0.64%
DOW - LRND
40%
Loosely correlated
-0.59%
CNH - LRND
31%
Poorly correlated
-6.10%
NXT - LRND
25%
Poorly correlated
+1.00%
More